Panacea Life Sciences Holdings, Inc. (PLSH)

Market Cap	2.44M -44.7%
Revenue (ttm)	2.76M +50.4%
Net Income	-7.67M
EPS	-0.45
Shares Out	59.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	24,349
Open	0.0410
Previous Close	0.0410
Day's Range	0.0410 - 0.0410
52-Week Range	0.0324 - 0.1996
Beta	3.30
RSI	44.54
Earnings Date	n/a

About PLSH

Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand names. It ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 40
• Stock Exchange: OTCMKTS
• Ticker Symbol: PLSH

Financial Performance

In 2023, PLSH's revenue was $2.38 million, an increase of 46.59% compared to the previous year's $1.63 million. Losses were -$8.02 million, -12.33% less than in 2022.